AdilDaudMD

PubMed

• Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations.
  Alexandra M Haugh, Robert C Osorio, Michael E Tawil, Michael Tetzlaff, Rony A Francois, Katy K Tsai, Adil Daud, Harish N Vasudevan> ;Cancers. 2024 Mar 29
• Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
  Paul Wong, Andrew D Wisneski, Katy K Tsai, Tammy T Chang, Kenzo Hirose, Eric K Nakakura, Adil I Daud, Ajay V Maker, Carlos U Corvera> ;World Journal of Surgical Oncology. 2024 Mar 11
• The therapeutically actionable long non-coding RNA 'T-RECS' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
  Feichtenschlager, V., Chen, L., Zheng, Y., Ho, W., Sanlorenzo, M., Vujic, I., Fewings, E., Lee, A., Chen, C., Callanan, C., Lin, K., Qu, T., Hohlova, D., Vujic, M., Hw...> ;Molecular Cancer. 2024 Feb 22
• Therapeutic Strategies in BRAF V600 Wild-Type Cutaneous Melanoma.
  Haugh, A., Daud, A.> ;American Journal of Clinical Dermatology. 2024 Feb 8
• The therapeutically actionable long non-coding RNA '' is essential to cancer cells' survival in NRAS/MAPK-driven melanoma.
  Feichtenschlager, V., Chen, L., Zheng, Y., Ho, W., Sanlorenzo, M., Vujic, I., Fewings, E., Lee, A., Chen, C., Callanan, C., Lin, K., Qu, T., Hohlova, D., Vujic, M., Hw...> ;Research Square. 2023 Dec 1
• 65 citations
  Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12.
  Christopher S Garris, Sean P Arlauckas, Rainer H Kohler, Marcel P Trefny, Seth Garren, Cécile Piot, Camilla Engblom, Christina Pfirschke, Marie Siwicki, Jeremy Gungabe...> ;Immunity. 2022 Sep 13
• 3 citations
  Pulsed Electric Fields in Oncology: A Snapshot of Current Clinical Practices and Research Directions from the 4th World Congress of Electroporation.
  Luca G Campana, Adil Daud, Francesco Lancellotti, Julio P Arroyo, Rafael V Davalos, Claudia Di Prata, Julie Gehl> ;Cancers. 2023 Jun 25
• 10 citations
  Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma.
  Caroline Robert, Matteo S Carlino, Catriona McNeil, Antoni Ribas, Jean-Jacques Grob, Jacob Schachter, Marta Nyakas, Damien Kee, Teresa M Petrella, Arnold Blaustein, Mi...> ;Journal of Clinical Oncology. 2023 Aug 20
• Pembrolizumab-associated chronic rhinosinusitis: A new endotype and management considerations.
  Taylor C Standiford, Neil N Patel, Amritpal Singh, Grant Gochman, Tara Jamie Wu, Adil I Daud, Andrew N Goldberg> ;International Forum of Allergy & Rhinology. 2023 Dec 1
• 1 citations
  Resistance to Immune Checkpoint Blockade: IFNγ or MHC-I?
  Alexandra Haugh, Adil Daud> ;Cancer Immunology Research. 2023 Jul 5
• 6 citations
  Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.
  Drew W Rasco, Theresa Medina, Pippa Corrie, Anna C Pavlick, Mark R Middleton, Paul Lorigan, Chris Hebert, Ruth Plummer, James Larkin, Sanjiv S Agarwala, Adil I Daud, J...> ;Cancer Chemotherapy and Pharmacology. 2023 Jul 1
• 11 citations
  Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study.
  Filippo de Braud, Christophe Dooms, Rebecca S Heist, Celeste Lebbe, Martin Wermke, Anas Gazzah, Dirk Schadendorf, Piotr Rutkowski, Jürgen Wolf, Paolo A Ascierto, Ignac...> ;Journal of Clinical Oncology. 2023 May 10
• 4 citations
  Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity.
  Jack Y Lee, Bianca Nguyen, Anandaroop Mukhopadhyay, Mia Han, Jun Zhang, Ravindra Gujar, Jon Salazar, Reneta Hermiz, Lauren Svenson, Erica Browning, H Kim Lyerly, David...> ;Molecular Therapy Oncolytics. 2022 Jun 16
• 6 citations
  Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity.
  Mia Han, Bianca Nguyen, Jack Y Lee, Erica Browning, Jun Zhang, Anandaroop Mukhopadhyay, Ravindra Gujar, Jon Salazar, Reneta Hermiz, Lauren Svenson, Annah S Rolig, Will...> ;Molecular Cancer Research. 2022 Jun 3
• 7 citations
  Intratumoral therapies and in-situ vaccination for melanoma.
  Laura A Huppert, Adil I Daud> ;Human Vaccines & Immunotherapeutics. 2022 May 31
• A Dual Approach on Experimental, Theoretical Insight of Structural Elucidation, Hirshfeld Surface Analysis, Optical and Electrochemical Properties of Acyl Thiourea-Eth...
  Adibah Izzati Daud, Wan M Khairul, Suhana Arshad, Ibrahim Abdul Razak, Diana L Nossa González, Mauricio F Erben> ;Journal of Chemical Crystallography. 2022 Jan 1
• 15 citations
  TCR-sequencing in cancer and autoimmunity: barcodes and beyond.
  Kristen E Pauken, Kaitlyn A Lagattuta, Benjamin Y Lu, Liliana E Lucca, Adil I Daud, David A Hafler, Harriet M Kluger, Soumya Raychaudhuri, Arlene H Sharpe> ;Trends in Immunology. 2022 Mar 1
• 53 citations
  Discovering dominant tumor immune archetypes in a pan-cancer census.
  Alexis J Combes, Bushra Samad, Jessica Tsui, Nayvin W Chew, Peter Yan, Gabriella C Reeder, Divyashree Kushnoor, Alan Shen, Brittany Davidson, Andrea J Barczak, Michael...> ;Cell. 2022 Jan 6
• 4 citations
  Layilin Anchors Regulatory T Cells in Skin.
  Pooja Mehta, Victoire Gouirand, Devi P. Boda, Jingxian Zhang, Sofia V. Gearty, Bahar Zirak, Margaret M. Lowe, Sean Clancy, Ian C. Boothby, Kelly M. Mahuron, Adam Fries...> ;Journal of Immunology. 2021 Sep 1
• 43 citations
  Tissue-specific tregs in cancer metastasis: opportunities for precision immunotherapy.
  Laura A. Huppert, Michael D. Green, Luke Kim, Christine Chow, Yan Leyfman, Adil Daud, James Lee> ;Cellular & Molecular Immunology. 2021 Aug 20
• 1 citations
  Should Sentinel Lymph Node Biopsy Status Guide Adjuvant Radiation Therapy in Patients With Merkel Cell Carcinoma
  Tessnim R Ahmad, Harish N. Vasudevan, Ann A. Lazar, Jason Chan, Jonathan R. George, Michael Alvarado, Siegrid S. Yu, Adil Daud, Sue S. Yom> ;Advances in Radiation Oncology. 2021 Jul 31
• 31 citations
  The Liver-Immunity Nexus and Cancer Immunotherapy.
  James Lee, Michael D. Green, Laura A. Huppert, Christine Chow, Robert H. Pierce, Adil Daud> ;Clinical Cancer Research. 2021 Jul 20
• 2 citations
  Pembrolizumab and Ipilimumab as Second-Line Therapy for Advanced Melanoma.
  Laura A. Huppert, Adil Daud> ;Journal of Clinical Oncology. 2021 Jun 17
• 53 citations
  Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment.
  Kristen E. Pauken, Osmaan Shahid, Kaitlyn A. Lagattuta, Kelly M. Mahuron, Jacob M. Luber, Margaret M. Lowe, Linglin Huang, Conor Delaney, Jaclyn M. Long, Megan E. Fung...> ;The Journal of Experimental Medicine. 2021 Apr 5
• 48 citations
  Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma.
  Paul Nghiem, Shailender Bhatia, Evan J. Lipson, William H. Sharfman, Ragini R. Kudchadkar, Andrew S. Brohl, Philip Friedlander, Adil Daud, Harriet M. Kluger, Sunil Red...> ;Journal for Immunotherapy of Cancer. 2021 Apr 1
• Join now to see all

Lectures

• Epacadostat plus nivolumab for advanced melanoma: Updated phase 2 results of the ECHO-204 study. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018